First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial.
Saved in:
| Title: | First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. |
|---|---|
| Authors: | Quintero Aldana G; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Calle Doctor Ulises Romero, 1, 27003, Lugo, Spain. gquinteroaldana@gmail.com., Salgado M; Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Candamio S; Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., Méndez JC; Department of Medical Oncology, Centro Oncologico de Galicia, A Coruña, Spain., Jorge M; Department of Medical Oncology, Complejo Hospitalario Xeral Cíes, Vigo, Spain., Reboredo M; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Vázquez Tuñas L; Department of Medical Oncology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain., Romero C; Department of Medical Oncology, Hospital POVISA, Vigo, Spain., Covela M; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Calle Doctor Ulises Romero, 1, 27003, Lugo, Spain., Fernández Montes A; Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain., Carmona M; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Calle Doctor Ulises Romero, 1, 27003, Lugo, Spain., Vidal Insua Y; Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain., López R; Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; CIBERONC, Madrid, Spain. |
| Corporate Authors: | Galician Oncological Research Group (GGIO) |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2020 Apr; Vol. 22 (4), pp. 495-502. Date of Electronic Publication: 2019 Jul 06. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31280434 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Quintero+Aldana+G%22">Quintero Aldana G</searchLink>; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Calle Doctor Ulises Romero, 1, 27003, Lugo, Spain. gquinteroaldana@gmail.com.<br /><searchLink fieldCode="AU" term="%22Salgado+M%22">Salgado M</searchLink>; Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.<br /><searchLink fieldCode="AU" term="%22Candamio+S%22">Candamio S</searchLink>; Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22Méndez+JC%22">Méndez JC</searchLink>; Department of Medical Oncology, Centro Oncologico de Galicia, A Coruña, Spain.<br /><searchLink fieldCode="AU" term="%22Jorge+M%22">Jorge M</searchLink>; Department of Medical Oncology, Complejo Hospitalario Xeral Cíes, Vigo, Spain.<br /><searchLink fieldCode="AU" term="%22Reboredo+M%22">Reboredo M</searchLink>; Department of Medical Oncology, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.<br /><searchLink fieldCode="AU" term="%22Vázquez+Tuñas+L%22">Vázquez Tuñas L</searchLink>; Department of Medical Oncology, Complejo Hospitalario de Pontevedra, Pontevedra, Spain.<br /><searchLink fieldCode="AU" term="%22Romero+C%22">Romero C</searchLink>; Department of Medical Oncology, Hospital POVISA, Vigo, Spain.<br /><searchLink fieldCode="AU" term="%22Covela+M%22">Covela M</searchLink>; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Calle Doctor Ulises Romero, 1, 27003, Lugo, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+Montes+A%22">Fernández Montes A</searchLink>; Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense, Ourense, Spain.<br /><searchLink fieldCode="AU" term="%22Carmona+M%22">Carmona M</searchLink>; Department of Medical Oncology, Hospital Universitario Lucus Augusti, Calle Doctor Ulises Romero, 1, 27003, Lugo, Spain.<br /><searchLink fieldCode="AU" term="%22Vidal+Insua+Y%22">Vidal Insua Y</searchLink>; Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.<br /><searchLink fieldCode="AU" term="%22López+R%22">López R</searchLink>; Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; CIBERONC, Madrid, Spain. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Galician+Oncological+Research+Group+%28GGIO%29%22">Galician Oncological Research Group (GGIO)</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101247119%22">Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</searchLink> [Clin Transl Oncol] 2020 Apr; Vol. 22 (4), pp. 495-502. <i>Date of Electronic Publication: </i>2019 Jul 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Italia%22">Springer Italia </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>101247119 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1699-3055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221699048X%22">1699048X </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31280434 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12094-019-02151-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 495 Titles: – TitleFull: First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Quintero Aldana G – PersonEntity: Name: NameFull: Salgado M – PersonEntity: Name: NameFull: Candamio S – PersonEntity: Name: NameFull: Méndez JC – PersonEntity: Name: NameFull: Jorge M – PersonEntity: Name: NameFull: Reboredo M – PersonEntity: Name: NameFull: Vázquez Tuñas L – PersonEntity: Name: NameFull: Romero C – PersonEntity: Name: NameFull: Covela M – PersonEntity: Name: NameFull: Fernández Montes A – PersonEntity: Name: NameFull: Carmona M – PersonEntity: Name: NameFull: Vidal Insua Y – PersonEntity: Name: NameFull: López R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2020 Apr Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1699-3055 Numbering: – Type: volume Value: 22 – Type: issue Value: 4 Titles: – TitleFull: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Type: main |
| ResultId | 1 |